Exercise for Preeclampsia
(PAMPER Trial)
Trial Summary
The trial does not specify if you need to stop taking your current medications, but it excludes those taking medicines that affect fetal development.
Research suggests that regular physical activity, including aerobic exercise, may help reduce the risk of preeclampsia by improving blood vessel function and reducing oxidative stress (damage caused by free radicals). Studies have shown that women who engage in physical activity during pregnancy have a lower incidence of preeclampsia.
12345Research shows that exercise during pregnancy, including aerobic and resistance exercises, is generally safe for pregnant women, even those at risk for preeclampsia. Studies found no increase in adverse events or risks to mothers and babies, and exercise did not affect delivery methods or lead to health complications.
678910Exercise as a treatment for preeclampsia is unique because it focuses on physical activity to potentially reduce the risk and effects of the condition, unlike other treatments that may involve medication or early delivery. Studies suggest that exercise can have a protective effect against preeclampsia, offering a non-invasive and natural approach to managing the condition.
4791112Eligibility Criteria
This trial is for healthy women aged 18-40, less than 16 weeks pregnant with one baby. Participants should have a BMI between 18.5 and 45.0, lead a sedentary lifestyle, and must be cleared by their obstetric provider to join.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in aerobic, resistance, or combination exercise throughout pregnancy to assess effects on maternal and fetal/neonatal physiological variables.
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on birth outcomes and infant health.